Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia
Clinical trial NCT04103450 · COMPLETED
Trial details
- NCT number
- NCT04103450
- Sponsor
- Urovant Sciences GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-19
- Primary completion
- 2022-07-29
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.